Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More
Xconomy
DECEMBER 9, 2016
President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. —arguments from both sides of the epic CRISPR patent fight. And a trio of judges met to hear brief—can we say edited?—arguments
Let's personalize your content